Table of Contents
Chapter 1. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Executive Summary
1.1. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size & Forecast (2022- 2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Service Type
1.3.2. By Indication
1.3.3. By Therapy
1.3.4. By Phases
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Complexity of Advanced Therapeutic Modalities
3.1.2. Growing Pipeline of Advanced Therapeutic Products
3.1.3. Globalization of Clinical Trials
3.2. Market Challenges
3.2.1. Complex and Evolving Regulatory Landscape
3.2.2. High Cost of Advanced Therapeutics
3.3. Market Opportunities
3.3.1. Expanding Landscape of mRNA Therapies
3.3.2. Increasing Demand for Integrated Solutions
Chapter 4. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size & Forecasts by Service Type 2022-2032
5.1. Segment Dashboard
5.2. Global Advanced Therapeutics Pharmaceutical Outsourcing Market: Service Type Revenue Trend Analysis, 2022 & 2032 (USD Million)
5.2.1. Contract Research Organizations (CROs)
5.2.2. Contract Development and Manufacturing Organizations (CDMOs)
Chapter 6. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size & Forecasts by Indication 2022-2032
6.1. Segment Dashboard
6.2. Global Advanced Therapeutics Pharmaceutical Outsourcing Market: Indication Revenue Trend Analysis, 2022 & 2032 (USD Million)
6.2.1. Oncology
6.2.2. Neurology
6.2.3. Cardiology
6.2.4. Infectious Diseases
6.2.5. Others
Chapter 7. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size & Forecasts by Therapy 2022-2032
7.1. Segment Dashboard
7.2. Global Advanced Therapeutics Pharmaceutical Outsourcing Market: Therapy Revenue Trend Analysis, 2022 & 2032 (USD Million)
7.2.1. Cell Therapy
7.2.2. Gene Therapy
7.2.3. RNA-based Therapies
7.2.4. Others
Chapter 8. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size & Forecasts by Phases 2022-2032
8.1. Segment Dashboard
8.2. Global Advanced Therapeutics Pharmaceutical Outsourcing Market: Phases Revenue Trend Analysis, 2022 & 2032 (USD Million)
8.2.1. Preclinical Services
8.2.2. Clinical Services
8.2.3. Commercial Manufacturing and Packaging
Chapter 9. Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size & Forecasts by Region 2022-2032
9.1. North America Advanced Therapeutics Pharmaceutical Outsourcing Market
9.1.1. U.S. Advanced Therapeutics Pharmaceutical Outsourcing Market
9.1.1.1. Service Type breakdown size & forecasts, 2022-2032
9.1.1.2. Indication breakdown size & forecasts, 2022-2032
9.1.1.3. Therapy breakdown size & forecasts, 2022-2032
9.1.1.4. Phases breakdown size & forecasts, 2022-2032
9.1.2. Canada Advanced Therapeutics Pharmaceutical Outsourcing Market
9.2. Europe Advanced Therapeutics Pharmaceutical Outsourcing Market
9.2.1. UK Advanced Therapeutics Pharmaceutical Outsourcing Market
9.2.2. Germany Advanced Therapeutics Pharmaceutical Outsourcing Market
9.2.3. France Advanced Therapeutics Pharmaceutical Outsourcing Market
9.2.4. Spain Advanced Therapeutics Pharmaceutical Outsourcing Market
9.2.5. Italy Advanced Therapeutics Pharmaceutical Outsourcing Market
9.2.6. Rest of Europe Advanced Therapeutics Pharmaceutical Outsourcing Market
9.3. Asia-Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market
9.3.1. China Advanced Therapeutics Pharmaceutical Outsourcing Market
9.3.2. India Advanced Therapeutics Pharmaceutical Outsourcing Market
9.3.3. Japan Advanced Therapeutics Pharmaceutical Outsourcing Market
9.3.4. Australia Advanced Therapeutics Pharmaceutical Outsourcing Market
9.3.5. South Korea Advanced Therapeutics Pharmaceutical Outsourcing Market
9.3.6. Rest of Asia Pacific Advanced Therapeutics Pharmaceutical Outsourcing Market
9.4. Latin America Advanced Therapeutics Pharmaceutical Outsourcing Market
9.4.1. Brazil Advanced Therapeutics Pharmaceutical Outsourcing Market
9.4.2. Mexico Advanced Therapeutics Pharmaceutical Outsourcing Market
9.4.3. Rest of Latin America Advanced Therapeutics Pharmaceutical Outsourcing Market
9.5. Middle East & Africa Advanced Therapeutics Pharmaceutical Outsourcing Market
9.5.1. Saudi Arabia Advanced Therapeutics Pharmaceutical Outsourcing Market
9.5.2. South Africa Advanced Therapeutics Pharmaceutical Outsourcing Market
9.5.3. Rest of Middle East & Africa Advanced Therapeutics Pharmaceutical Outsourcing Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Croda International Plc
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. Charles River Laboratories International, Inc.
10.3.3. Catalent, Inc.
10.3.4. QuintilesIMS (IQVIA)
10.3.5. Parexel International Corporation
10.3.6. ICON plc
10.3.7. PPD, Inc. (Thermo Fisher Scientific)
10.3.8. LabCorp (Laboratory Corporation of America Holdings)
10.3.9. Syneos Health
10.3.10. WuXi AppTec
10.3.11. Lonza Group
10.3.12. Piramal Pharma Solutions
10.3.13. SGS SA
10.3.14. Evotec SE
10.3.15. CMC Biologics (Now AGC Biologics)
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes